Switch to:
Cryo-Cell International Inc  (OTCPK:CCEL) Cash Flow from Financing: $-5.95 Mil (TTM As of May. 2017)

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the three months ended in May. 2017, Cryo-Cell International Inc paid $0.32 Mil more to buy back shares than it received from issuing new shares. It spent {COMPANY->currency_symbol}{NetIssuanceofDebt_last_f} Mil paying down its debt. It paid $0.00 Mil more to buy back preferred shares than it received from issuing preferred shares. It received $0.00 Mil from paying cash dividends to shareholders. It received $0.02 Mil on other financial activities. In all, Cryo-Cell International Inc spent $0.80 Mil on financial activities for the three months ended in May. 2017.


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Cryo-Cell International Inc Annual Data

Nov07 Nov08 Nov09 Nov10 Nov11 Nov12 Nov13 Nov14 Nov15 Nov16
Cash Flow from Financing Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.95 -0.72 -2.59 -3.26 -5.27

Cryo-Cell International Inc Quarterly Data

Aug12 Nov12 Feb13 May13 Aug13 Nov13 Feb14 May14 Aug14 Nov14 Feb15 May15 Aug15 Nov15 Feb16 May16 Aug16 Nov16 Feb17 May17
Cash Flow from Financing Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.19 -3.59 -1.02 -0.56 -0.80

Calculation

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

Cryo-Cell International Inc's Cash from Financing for the fiscal year that ended in Nov. 2016 is calculated as:

Cryo-Cell International Inc's Cash from Financing for the quarter that ended in May. 2017 is

Cash Flow from Financing(Q: May. 2017 )
=Net Issuance of Stock+Net Issuance of Debt+Net Issuance of Preferred Stock+Cash Flow for Dividends+Other Financing
=-0.315+-0.5+{NetIssuanceofpreferred_last}}+0+0.018
=-0.80

Cash Flow from Financing for the trailing twelve months (TTM) ended in May. 2017 was -3.585 (Aug. 2016 ) + -1.017 (Nov. 2016 ) + -0.555 (Feb. 20 ) + -0.797 (May. 2017 ) = $-5.95 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Explanation

Cash from financing contains five items:

1. Net Issuance of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. If this number is positive, it means that the company has received more cash from issuing shares than it has paid to buy back shares. If this number is negative, it means that company has paid more cash to buy back shares than it has received for issuing shares.

Cryo-Cell International Inc's net issuance of stock for the three months ended in May. 2017 was $-0.32 Mil. Cryo-Cell International Inc paid $0.32 Mil more to buy back shares than it received from issuing new shares.

2. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Cryo-Cell International Inc's net issuance of debt for the three months ended in May. 2017 was $-0.50 Mil. Cryo-Cell International Inc spent $0.50 Mil paying down its debt.

3. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Cryo-Cell International Inc's net issuance of preferred for the three months ended in May. 2017 was $0.00 Mil. Cryo-Cell International Inc paid $0.00 Mil more to buy back preferred shares than it received from issuing preferred shares.

4. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cryo-Cell International Inc's cash flow for dividends for the three months ended in May. 2017 was $0.00 Mil. Cryo-Cell International Inc received $0.00 Mil from paying cash dividends to shareholders.

5. Other Financing:
Money spent or earned by company from other financial activities.

Cryo-Cell International Inc's other financing for the three months ended in May. 2017 was $0.02 Mil. Cryo-Cell International Inc received $0.02 Mil on other financial activities.


Related Terms


Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK